LabGenomics Co., Ltd. (KOSDAQ:084650)

South Korea · Delayed Price · Currency is KRW

815.00

-8.00 (-0.97%)

Aug 11, 2026, 3:30 PM KST

LabGenomics Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	84,190	88,161	85,898	71,076	144,773	202,407
Revenue Growth	-4.22%	2.63%	20.85%	-50.91%	-28.48%	69.41%
Gross Profit	27,763	29,375	30,184	29,499	96,121	124,886
Operating Income	-53,380	-54,917	-18,491	-6,923	66,206	104,518
Net Income	-63,708	-64,375	-23,796	-4,674	48,397	83,855
Earnings Per Share	-858.13	-867.11	-322.00	-62.96	714.50	1240.50
EPS Growth	-	-	-	-	-42.40%	91.05%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	53,871	58,019	90,864	115,391	136,971	98,998
Total Debt	61,466	55,499	50,202	49,994	21,228	5,321
Net Cash (Debt)	-7,596	2,520	40,662	65,396	115,743	93,678
Net Cash Growth	-	-93.80%	-37.82%	-43.50%	23.55%	96.42%
Net Cash Per Share	-102.31	33.94	550.23	880.88	1709.14	1386.06

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-28,494	-30,536	-12,995	-3,827	68,955	65,362
Capital Expenditures	-1,257	-1,138	-3,669	-4,990	-37,648	-13,717
Free Cash Flow	-29,751	-31,674	-16,663	-8,817	31,307	51,645
Free Cash Flow Growth	-	-	-	-	-39.38%	13.08%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	32.98%	33.32%	35.14%	41.50%	66.39%	61.70%
Operating Margin	-63.40%	-62.29%	-21.53%	-9.74%	45.73%	51.64%
Pretax Margin	-69.96%	-68.35%	-30.21%	-10.04%	43.79%	53.92%
Profit Margin	-75.67%	-73.02%	-27.70%	-6.58%	33.43%	41.43%
FCF Margin	-35.34%	-35.93%	-19.40%	-12.40%	21.63%	25.52%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	4.43	3.35
P/FCF Ratio	-	-	-	-	6.84	5.44
PS Ratio	0.73	1.53	2.15	4.03	1.48	1.39